ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
The role of subcortical brain tissue iron as an indicator of dopamine neurophysiology in adolescent cannabis use.
Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Approximately 10-20% of U.S. adolescents report past-year cannabis use (CU). Although regular CU beginning in adolescence is expected to blunt dopamine-related neurophysiology, this hypothesis has not been tested in adolescents due to methodological limitations. However, neurophysiology contributing to dopamine can be noninvasively indexed via subcortical tissue iron measured with magnetic resonance imaging (MRI). We examined adolescent CU quantity, frequency, and problems in relation to tissue iron in regions with high dopamine activity, hypothesizing that greater CU would be linked to less tissue iron. Adolescents (n = 81; 64.2% female) aged 14-17 reporting either fewer than 5 lifetime cannabis episodes (n = 47) or more than 11 episodes (n = 34), with limited alcohol and nicotine use and no other illicit substance use, completed substance use assessments and an MRI. We calculated the inverse of the normalized T2* measurement (1/nT2*; lower values indicate less tissue iron) from resting-state functional scans by assessing relative T2* decay. 1/nT2* was estimated using subcortical masks for hypothesized regions. Lower 1/nT2* signal was associated with increased daily concentrate hits (b = -0.01, p < 0.001), cannabis hours high (b = -0.01, p = 0.016), CU frequency (b = -0.01, p = 0.01), and cannabis use disorder (CUD) severity (b = -0.01, p = 0.003). Post-hoc analyses highlighted the VTA as a key region. Results align with reduced dopamine-related neurophysiology associated with CU in adult and animal samples, and have implications for understanding adolescent CUD development. Measuring 1/nT2* offers an innovative, non-invasive method to index neurobiological alterations in adolescent CU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.